Targeting melanoma by small molecules: Challenges ahead

Abstract

Significant progress has been made in targeting melanoma using small molecule inhibitors, but challenges remain. Here we describe the history of screening approaches in melanoma and their limitations. We propose several approaches to refine our screening models to enhance the discovery process. It is hoped that this discussion will stimulate further improvements in our development of small molecules inhibitors for treatment of melanoma patients. © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.